Pradaxa Lawsuit News: New Order Stays All Pradaxa Bleeding Cases Pending in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports

The Firm is investigating potential Pradaxa lawsuits on behalf of individuals who allegedly suffered uncontrollable internal bleeding due to Pradaxa.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Free Case Review
Our Firm continues to hear from Pradaxa users who allegedly suffered uncontrollable internal bleeding due to this medication. We look forward to further progress in this litigation.

(PRWEB) May 25, 2014

The federal judge overseeing thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/)
in the U.S. District Court, Southern District of Illinois, has stayed all cases pending further notice from the Court, Bernstein Liebhard LLP reports. According to an Order dated May 20, 2014, U.S. District Judge David R. Herndon also convened a meeting in his chambers on May 21st to discuss the current status of the litigation’s ongoing settlement negotiations. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“Our Firm continues to hear from Pradaxa users who allegedly suffered uncontrollable internal bleeding due to this medication. We look forward to further progress in this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free and confidential case evaluations to patients who were allegedly harmed by Pradaxa.

Pradaxa Bleeding Side Effects
Pradaxa is a blood thinner that was approved in 2010 to prevent strokes in people with atrial fibrillation. Court documents indicate that nearly 2,700 lawsuits have been filed in the Southern District of Illinois on behalf of alleged victims of Pradaxa bleeding side effects. All of the lawsuits claim that Pradaxa was wrongly positioned as an improvement over warfarin, a blood thinner that has been used for decades. Among other things, plaintiffs claim that the company failed to warn that unlike warfarin, there exists no readily available antidote to reverse the internal bleeding that is known to sometimes occur with Pradaxa use. Warfarin bleeding can be stopped via the administration of vitamin K.

In February, 7 Action News in Detroit revealed that the U.S. Food & Drug Administration (FDA) has received reports of 12,494 injuries and 1,158 deaths among Pradaxa users since the blood thinner was launched in the U.S. in October 2010. Many of these cases detailed episodes of uncontrollable internal bleeding among Pradaxa patients. The report also noted that among all of the drugs monitored by the FDA, Pradaxa was the subject of the most complaints in both 2010 and 2011.*

Pradaxa patients who were allegedly harmed by the drug’s bleeding side effects may be entitled to file their own Pradaxa lawsuit. To learn more about the litigation involving Pradaxa, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to schedule a free, no obligation case review.

*wxyz.com/money/consumer/pradaxa-lawsuit, 7 Action News, February 25, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.pradaxalawsuithelp.com/
https://plus.google.com/115936073311125306742?rel=author